10-Q Filing

GLUCOSE HEALTH, INC. CIK: 1420108 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001477932-13-002137`
Period End Date	20130331
Filing Date	20130506
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	bisu-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 48 Income Statement 57 Cash Flow Statement 59

Balance Sheet 48 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$1.08K	USD	Point-in-time
Cash	`Cash`	$2.77K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$40.71K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	116.58M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.08K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$43.49K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.09M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	116.58M	shares	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	101.09M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$250.09K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$207.68K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$123.20K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$145.42K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	$136.13K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	-	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$12.10K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	-	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.62K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.60K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$63.17K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$60.68K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$185.48K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$358.44K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$185.48K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$358.44K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 116,578,612 and 101,085,862 shares issued and outstanding as of March 31, 2013 and December 31, 2012, respectively	`CommonStockValue`	$116.58K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 116,578,612 and 101,085,862 shares issued and outstanding as of March 31, 2013 and December 31, 2012, respectively	`CommonStockValue`	$101.09K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$3.59M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$3.77M	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-150.00K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-244.94K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$568.65K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$804.35K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Total stockholders' equity (deficiency)	`StockholdersEquity`	$-108.35K	USD	Point-in-time
Total stockholders' equity (deficiency)	`StockholdersEquity`	$22.20K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)	`LiabilitiesAndStockholdersEquity`	$207.68K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)	`LiabilitiesAndStockholdersEquity`	$250.09K	USD	Point-in-time

Income Statement 57 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	6 Qtrs
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	$3.63K	USD	6 Qtrs
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	1 Quarter
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	1 Quarter
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	1 Quarter
Total Cost of Revenues	`CostOfGoodsSold`	$3.63K	USD	6 Qtrs
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	$-3.63K	USD	6 Qtrs
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	1 Quarter
Professional fees	`SalariesAndWages`	$183.26K	USD	1 Quarter
Professional fees	`SalariesAndWages`	$620.54K	USD	6 Qtrs
Professional fees	`SalariesAndWages`	$5.68K	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$85.29K	USD	6 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.30K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$15.52K	USD	6 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.25K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$721.35K	USD	6 Qtrs
Total Operating Expenses	`OperatingExpenses`	$192.51K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$6.98K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-724.99K	USD	6 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-6.98K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-192.51K	USD	1 Quarter
Interest expense	`InterestExpense`	$734.00	USD	1 Quarter
Interest expense	`InterestExpense`	$79.36K	USD	6 Qtrs
Interest expense	`InterestExpense`	$43.19K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-79.36K	USD	6 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-734.00	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-43.19K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-235.70K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-7.71K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-804.35K	USD	6 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	67.19M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	108.77M	shares	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-235.70K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.71K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-804.35K	USD	6 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-12.58K	USD	6 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-6.51K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-14.23K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-235.70K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-816.92K	USD	6 Qtrs

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-235.70K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.71K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-804.35K	USD	6 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment expense	`AssetImpairmentCharges`	$85.29K	USD	6 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$160.69K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$513.06K	USD	6 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-42.07K	USD	1 Quarter
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	1 Quarter
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-76.37K	USD	6 Qtrs
(Increase) decrease in prepaids	`IncreaseDecreaseInPrepaidExpense`	-	USD	1 Quarter
(Increase) decrease in prepaids	`IncreaseDecreaseInPrepaidExpense`	$40.71K	USD	1 Quarter
(Increase) decrease in prepaids	`IncreaseDecreaseInPrepaidExpense`	$40.71K	USD	6 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$23.34K	USD	1 Quarter
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$6.69K	USD	1 Quarter
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$31.35K	USD	6 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$665.35K	USD	6 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$185.39K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$6.69K	USD	1 Quarter
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-138.99K	USD	6 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.02K	USD	1 Quarter
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-50.30K	USD	1 Quarter
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$10.61K	USD	6 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$12.00K	USD	1 Quarter
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	1 Quarter
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	1 Quarter
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	$4.87K	USD	6 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	1 Quarter
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$116.85K	USD	6 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$16.01K	USD	1 Quarter
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$40.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$132.33K	USD	6 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$52.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.01K	USD	1 Quarter
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.51K	USD	6 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-33.00	USD	1 Quarter
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	-	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$14.95K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.70K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.16K	USD	6 Qtrs
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.08K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.93K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$15.03K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$2.77K	USD	Point-in-time
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	-	USD	1 Quarter
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$98.21K	USD	6 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$34.07K	USD	1 Quarter
Conversion of liability to common stock	`StockIssued1`	$47.80K	USD	6 Qtrs
Conversion of liability to common stock	`StockIssued1`	-	USD	1 Quarter
Conversion of liability to common stock	`StockIssued1`	$41.50K	USD	1 Quarter
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$6.60K	USD	6 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	1 Quarter
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	1 Quarter
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	1 Quarter
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	1 Quarter
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$291.56K	USD	6 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.